A Predictive Score for the Ischemic Etiology of a Transient Diplopia

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The transient diplopias (TD) is defined by a short diplopia. Their etiology may be ophthalmological, neurological non-ischemic or of ischemic origin. The difficulty is to recognize an ischemic mechanism which imposes emergency cares. A clinical score could help the clinician to recognize the etiology of the TD .

See also
Status	Clinical Trial	Phase
Completed	`NCT04957745` - Understanding Visual Confusion Using Stereoscopic Displays	N/A
Completed	`NCT03660852` - Impact of a Magnetic Resonance Imaging (MRI) Scanner Exclusively Dedicated to Emergency in the Clinical Management of Patients Presenting With Diplopia or Dizziness
Recruiting	`NCT01119144` - Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial	Phase 2

NCT number	NCT02576925
Study type	Observational
Source	Fondation Ophtalmologique Adolphe de Rothschild
Contact	Michel Rosenheim, MD, DSc
Phone	+33148036457
Email	mrosenheim@fo-rothschild.fr
Status	Recruiting
Phase
Start date	September 24, 2015
Completion date	December 23, 2025

A Predictive Score for the Ischemic Etiology of a Transient Diplopia (VASCO-DIP) — VASCO-DIP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms